187 related articles for article (PubMed ID: 6312922)
1. Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients.
Segal-Eiras A; Croce MV; Pasqualini CD
Arch Geschwulstforsch; 1983; 53(4):321-7. PubMed ID: 6312922
[TBL] [Abstract][Full Text] [Related]
2. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
[TBL] [Abstract][Full Text] [Related]
3. Antibody reacting with the murine mammary tumor virus in the serum of patients with breast carcinoma: a possible serological detection method for breast carcinoma.
Holder WD; Wells SA
Cancer Res; 1983 Jan; 43(1):239-44. PubMed ID: 6291754
[TBL] [Abstract][Full Text] [Related]
4. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
Rapp L; Fuji H
Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
[TBL] [Abstract][Full Text] [Related]
5. [Presence of antibodies specifically reacting with structural proteins of the mammary cancer virus among antibodies found in circulating immune complexes in patients with breast cancer].
Litvinov SV; Malivanova TF; Chuev IuV; Kriukova IN
Biull Eksp Biol Med; 1988 Apr; 105(4):475-7. PubMed ID: 2833956
[TBL] [Abstract][Full Text] [Related]
6. Specificities of heterologous antisera against human leukaemia cells. 1. Reactions against leukaemia cells.
Thränhardt H; Milleck J; Zintl F; Koppitz D; Plenert W; Raderecht C; Richter KV
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):463-74. PubMed ID: 83265
[TBL] [Abstract][Full Text] [Related]
7. Antibodies cross-reacting with Gross virus detected in human acute leukemia and Hodgkin lymphoma.
Dosne Pasqualini C; Di Girolamo MT; Segal Eiras A; Laguens RP
Medicina (B Aires); 1980; 40(3):289-94. PubMed ID: 7001168
[No Abstract] [Full Text] [Related]
8. Studies on Paul-Bunnell (P-B) antigen-antibody system. II. P-B antigens in extracts of lymphoma-leukemia spleens and pathologic sera.
Masaki M; Kano K; Merrick JM; Milgrom F
J Immunol; 1981 Jul; 127(1):5-8. PubMed ID: 6972412
[TBL] [Abstract][Full Text] [Related]
9. Humoral cross immunity in patients with malignant tumors.
Harlozinska A; Albert Z; Richter R; Singer Z; Salwa J
Arch Immunol Ther Exp (Warsz); 1971; 19(6):835-49. PubMed ID: 4946994
[No Abstract] [Full Text] [Related]
10. [Humoral antibodies to structural proteins of murine mammary tumor virus as a potential immunologic marker of human breast cancer].
Malivanova TF; Kriukova IN; Litvinov SV; Ermilova VD; Shirin DF; Blokhina NG
Vopr Onkol; 1995; 41(1):43-6. PubMed ID: 7667940
[TBL] [Abstract][Full Text] [Related]
11. Serum antibody reacting with placental syncytiotrophoblast in sera of patients with autoimmune diseases--a possible relation to type C RNA retrovirus.
Maeda S; Yonezawa K; Yachi A
Clin Exp Immunol; 1985 Jun; 60(3):645-53. PubMed ID: 2990781
[TBL] [Abstract][Full Text] [Related]
12. [Humoral antibodies to the antigens related to the structural protein antigens of the mammary cancer virus (MTV) in breast cancer patients and in healthy donors].
Litvinov SV; Remennik IV; Kriukova IN
Biull Eksp Biol Med; 1984 May; 97(5):600-3. PubMed ID: 6326892
[TBL] [Abstract][Full Text] [Related]
13. Autogenous immunity to endogenous RNA tumor virus antigens in mice with a low natural incidence of lymphoma.
Hanna MG; Tennant RW; Yuhas JM; Clapp NK; Batzing BL; Snodgrass MJ
Cancer Res; 1972 Oct; 32(10):2226-34. PubMed ID: 4117035
[No Abstract] [Full Text] [Related]
14. Natural antibodies to simian type-C viruses and human retrovirus HTLV in patients with lymphoid malignancies.
Tóth FD; Szabó B; Váczi L; Kiss A; Kovács I; Rák K; Kiss C; Gallo RC
Acta Microbiol Hung; 1984; 31(4):387-92. PubMed ID: 6100223
[TBL] [Abstract][Full Text] [Related]
15. Paul-Bunnell antigen in lymphoma and leukemia spleens.
Kano K; Fjelde A; Milgrom F
J Immunol; 1977 Sep; 119(3):945-9. PubMed ID: 268381
[TBL] [Abstract][Full Text] [Related]
16. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma.
Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Takenaka T; Ishihara K; Watanabe S; Hoshino H; Miwa M; Kinoshita M; Okabe S; Fukushima N; Inada N
Jpn J Clin Oncol; 1983; 13 Suppl 2():165-87. PubMed ID: 6603526
[TBL] [Abstract][Full Text] [Related]
17. Detection and analysis of antibodies against retrovirus determinants in the sera of haematologic patients.
Etkin AF; Litvinov SV; Gurevich MM
Acta Virol; 1989 Mar; 33(2):151-61. PubMed ID: 2569811
[TBL] [Abstract][Full Text] [Related]
18. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to retroviruses of types C and D in female patients with benign and malignant mammary tumours.
Malivanova TF; Litvinov SV
Acta Virol; 1990 Feb; 34(1):19-26. PubMed ID: 1975721
[TBL] [Abstract][Full Text] [Related]
20. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
